chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient with 2 COVID vaccinations who admitted to hospital with postpartum hypertension and seizure and positive COVID test.  Asymptomatic for COVID during stay.  Provider d/c note below:  "20 YO P0101 who was admitted on 6/2/22 through ED due to severe range BPs.  She was 6 days s/p SVD at 36 wks; had IOL due to IUGR and PreE.  MgSO4 bolus was given in ED, but pt subsequently had Ecclamptic seizure after arriving to L&D.  She got Versed, and MgSO4 was re-bolused and continuous infusion was started.  IV antihypertensives were given, and BPs improved.  She had MgSO4 for 24+ hrs, and PO Procardia XL 60 mg qd was started.  Pt was monitored for 24 hrs off MgSO4, and BPs remained normal vs mildly elevated.  PreE labs initially showed mildly elevated AST and ALT; Plts normal.  AST subsequently normalized; ALT remained slightly elevated.  Pt was asymptomatic on day of discharge.  She will be D/C'd with Rx for Procardia, and will follow-up for BP check in office in 3 days."
This spontaneous report was received from a registered nurse, referring to an unspecified number of patients of unknown age and gender. No medical history or concurrent conditions were reported. On an unknown date, unspecified number of patients were vaccinated with an improperly stored oral, ROTATEQ (strength, dose and frequency not reported) lot # L000425, expiry date 21-JUN-2016 and lot # K016261, expiry date 23-JUN-2016. No concomitant therapies were reported. No adverse effects were reported. This is one of three reports from the same source (MARRS linked cases 1508USA002613 and 1508USA004472). Additional information has been requested.
she also stated her mother has an autoimmune disease; This is a spontaneous report from a non-contactable consumer (patient daughter) from a Pfizer-sponsored program. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE,Solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced an autoimmune disease on an unspecified date. Caller wanted to know if it's true that the Pfizer covid-19 vaccine had been already approved or not. Caller mentioned her mother who had 1st dose and wanted to know about the approval of the vaccine because she was worried and she also stated her mother has an autoimmune disease. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Some booster vaccines that were past 30 days in fridge; Expired vaccine administered/Booster vaccine that was past 30 days in fridge given after 45 days in refrigerator; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered/Booster vaccine that was past 30 days in fridge given after 45 days in refrigerator) and PRODUCT STORAGE ERROR (Some booster vaccines that were past 30 days in fridge) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002M21A) for COVID-19 vaccination.     No Medical History information was reported.    In May 2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In May 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered/Booster vaccine that was past 30 days in fridge given after 45 days in refrigerator). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Some booster vaccines that were past 30 days in fridge). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered/Booster vaccine that was past 30 days in fridge given after 45 days in refrigerator) and PRODUCT STORAGE ERROR (Some booster vaccines that were past 30 days in fridge) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  Patient took 2nd booster.  No treatment medication was reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2022: patient demographics added, dose details added
tested positive for COVID-19; tested positive for COVID-19; cough; fatigue; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 58-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: EN6204), via an unspecified route of administration, administered in left arm on 17Mar2021 at 12:30 (at the age of 58 years old) at a single dose for COVID-19 immunisation. Medical history included diabetes, high blood pressure, high cholesterol, all were ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ongoing metformin HCL at 1000 mg for diabetes, ongoing fenofibrate at 135 mg, once a day and ongoing amlodipine besilate, atorvastatin calcium once a day (5-40 mg once daily). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, the caller tested positive for COVID-19. He was and continues to be symptomatic. He stated that he still had a cough and fatigue on an unspecified date in 2021. He also stated that his 10 day required isolation period would be completed and he would like to know if he should proceed with receiving his second dose of the Pfizer COVID-19 vaccine on 07Apr2021 as scheduled. Patient was scheduled to receive his second dose on 07Apr2021. The patient underwent Covid-19 test performed on 30Mar2021 positive results were yielded on 31Mar2021. The patient was treated for the cough with cough pills. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Auto  immuneinner  Ear Disease in her right ear.; Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of AUTOIMMUNE INNER EAR DISEASE (Auto  immuneinner  Ear Disease in her right ear.) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Meniere's disease (Left ear) in 2019. Concomitant products included FAMOTIDINE (PEPCID [FAMOTIDINE]), DENOSUMAB (PROLIA), PREDNISONE, LEVOTHYROXINE, METOPROLOL TARTRATE (METOPROLOL XL) and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AUTOIMMUNE INNER EAR DISEASE (Auto  immuneinner  Ear Disease in her right ear.) (seriousness criterion medically significant) and VERTIGO (Vertigo). The patient was treated with AZATHIOPRINE (IMURAN [AZATHIOPRINE]) at an unspecified dose and frequency and MYCOPHENOLATE MOFETIL (CELLCEPT [MYCOPHENOLATE MOFETIL]) at an unspecified dose and frequency. At the time of the report, AUTOIMMUNE INNER EAR DISEASE (Auto  immuneinner  Ear Disease in her right ear.) and VERTIGO (Vertigo) outcome was unknown.            Patient was treated with Imuran and was discontinued due to high Liver Enzymes and then patient was  placed on Cellcept .   This case was linked to MOD-2021-285739 (Patient Link).; Sender's Comments: This case concerns a 72-year-old female, with a history of Meniere's disease (left ear), who developed serious unexpected events of autoimmune inner ear disease (right ear) with associated vertigo. Event latency 2 weeks after first dose mRNA-1273. Event outcome unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Vomiting. Occurred within a few hours after the shot. Child acting normal all day before the vaccination. Late that night we called the hospital to see if he should be brought in. We decided on the phone to see if it got any worse before doing so.
Pt did not have an adverse event but a vaccine was administered in error by someone else (state worker) on 2/8/23. Pt received his 1st Bivalent booster on 11/9/22 and another bivalent booster on 2/8/23.  Pt made aware of error,  did not have any reactions while waiting his 15 min after vaccination in clinic. Pt instructed to make us aware if any adverse reactions should occur after vaccination.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 03-MAY-2016, the patient was inadvertently vaccinated with an expired dose of ZOSTAVAX (lot # L000450, expiration date 09-MAR-2016, exact dose and route of administration were not reported). No adverse effect was reported. No product quality complaint (PQC) was involved. Additional information has been requested.
pt recvd Engerix-B & p/3rd dose pt reported medicine breath p/sweating;
Felt trash after getting the vaccine; Fever; Fatigue; Brain fog; Leg pain; Muscle pain; Swollen glands; Joint paint; This is a spontaneous report from a contactable consumer or other non-HCP (patient father). A 16-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number-not reported) via an unspecified route of administration on an unspecified date as dose 2, single and received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number-not reported) via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient felt trash after getting the vaccine, he experienced almost all side effects listed on the fact sheet for almost 3 weeks and side effects experienced are fever, fatigue that inhibits him to train for his sport, brain fog that caused missed school days, leg pain fir 20 days, muscle pain, swollen glands for 14 days, joint paint for 16 days, as reporter would be driving his son now to the doctor appointment. Reporter questioned about if we have any data as to any disproportionate adverse events experienced by younger recipient's vs that of the older ones. (In short, if AEs where way worst for younger than older recipients), is that if side effects are more severe if recipients had contracted COVID and had been asymptomatic and not know while vaccine was administered, if there is any way to distinguish if recipient's developed immunity was a result of natural immune's response in fighting off COVID19 infection or if this was attributed by the vaccine, could the side effects be possibly be brought about by receiving another dose of another COVID19 vaccine by mistake (another manufacturer, that given the side effects experienced, should he receive possible additional doses (booster shot) of the PFIZER-BIONTECH COVID-19 VACCINE in the future, is that could the side effects be possibly be brought about by mishandling of the vaccine outside of its recommended storage conditions. The outcome of all events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
burning; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.   A 64-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Telosa Hunt Syndrome" (unspecified if ongoing); "Melanoma" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing); "Type 1 diabetes" (unspecified if ongoing); "ran over by car" (unspecified if ongoing); "stiff shoulders" (unspecified if ongoing). Concomitant medication(s) included: METHOTREXATE; ACTEMRA; MYCOPHENOLATE; CELLCEPT [MYCOPHENOLATE MOFETIL HYDROCHLORIDE]; NOVOLOG. The following information was reported: BURNING SENSATION (non-serious), outcome "unknown", described as "burning".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose12/30/20 2nd dose01/20/21 Diagnosed covid positive:08/19/21 Symptom onset:08/17/21 Exposure:travel Symptoms:fever, cough, muscle aches,diarrhea, chills HA
Elevated heart rate beginning at approximately 8 PM (7 hours post injection). Heart rate was consistently above 100 bpm, with a local max of 116 bpm, until 11:59 PM. Heart rate remained elevated between 85 bpm to 105 bpm until approximately 8 AM the following day (4/1).  Patient was in bed for the entire during of the above event. Normal heart rate during that period of time is between high 40's and mid 50's.
approx 1hr p/vax pt began trembling making resp noises,glazed stare;episode lasted 10-15mins;no post-dictal state;was sl lethargic on arrival to ER but w/in 10-15mins was nl;
Serum sickness with arthralgias, myalgias 3 days after injection to present.
Information has been received from a female pharmacist who at the age of 13, in approximately 1991, was vaccinated subcutaneously with her second dose of 0.5 ml MMR II.  The pharmacist does not recall at what age she received her first dose of MMR II.  In JUL-2006 the patient underwent a titer test.  The results showed no immunity to any of the vaccine components.  The pharmacist was vaccinated subcutaneously with her third dose of MMR II in AUG 2006.  A subsequent titer test was performed which showed that she was immune.  The pharmacist did not know if she had seroconverted after she received the vaccine as a child.  No reaction was reported with this vaccination.  Unspecified medical attention was sought.  There was no product quality complaint.  Additional information has been requested.
red rash on bilateral arms; injection site redness and swelling; injection site redness and swelling; This spontaneous case was reported by a nurse and describes the occurrence of RASH ERYTHEMATOUS (red rash on bilateral arms), VACCINATION SITE SWELLING (injection site redness and swelling) and VACCINATION SITE ERYTHEMA (injection site redness and swelling) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021 at 6:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021 at 4:30 AM, the patient experienced RASH ERYTHEMATOUS (red rash on bilateral arms), VACCINATION SITE SWELLING (injection site redness and swelling) and VACCINATION SITE ERYTHEMA (injection site redness and swelling). At the time of the report, RASH ERYTHEMATOUS (red rash on bilateral arms), VACCINATION SITE SWELLING (injection site redness and swelling) and VACCINATION SITE ERYTHEMA (injection site redness and swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered RASH ERYTHEMATOUS (red rash on bilateral arms) to have an unknown relationship. No further causality assessments were provided for VACCINATION SITE SWELLING (injection site redness and swelling) and VACCINATION SITE ERYTHEMA (injection site redness and swelling).    No concomitant medication was reported.  Treatment information not provided.    Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up received on 07-May-2021 contains no significant information
fever ranging to 99-101.9; This is a spontaneous report from a contactable consumer (patient, reported for self).  An unspecified age female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown; Formulation: solution for injection; Expiration date: unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 05Feb2021 at 10:00, the patient experienced fever ranging to 99-101.9(units not reported). The patient underwent lab tests and procedures which included body temperature: 99-101.9 (units not reported) on 05Feb2021. Patient wanted to know if she can take Tylenol since she heard that it might dampen the effect of the vaccine. Patient wanted to know what was the maximum that this fever can reach, and mentioned that she was hesitant to take Tylenol and would hold back on it while she can. The outcome of the event fever ranging to 99-101.9 was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
3-6-06 Pt had Hep A #1, Dtap #4 right thigh, PCV #4 L thigh. On 3-7-06 Pt was seen by Dr, Dx allergic reaction (to vaccine) Rx; Augmentin 600 ES and Motrin 100mg,5cc). Sx: redness and swollen. 3-8-06 was also seen.
I started having chest pains that ran up to part of my neck at about 6 PM when we were out taking our evening walk. We had dinner and then it started to increase in pain. When we went to bed the pain was so intense that I could not lay down. Because we are very cognitive of the possibility of me having heart problems we went to the ER at about 10:30. They sat me down in the hallway. They did an EKG, blood pressure, blood work, x-ray because I had had pulmonary embolisms in 2011. I finally just left because it was taking a really long time and I was sitting in the hallway. I got the test results the next day and everything came back normal. Because of my fibromyalgia I figured it was just a flare up. The pain subsided on Thursday but Friday it came back. Again I believe it was a flare up. It went away. On Saturday I had an irregular heartbeat. It woke me up. I have a heart monitor and it indicated I had an irregular heartbeat. About 45 min that completely subsided.
.HYPOXEMIA 2/27/2023  &   1/27/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
FATIGUE, SEVERE BODY ACHES, INCREASED PAIN IN AREAS WITH PROBLEMS, FREEZING COLD WITH 4 THICK BLANKETS ON, WEAK, UP TO 36 HOURS IN BED  CONTINUALLY.  BAD DREAMS CONSTANT  THEN OUT OF BALANCE NAUSEATED, OUT OF SORTS, ACHY  FOR THE SECOND COMPLETE DAY, BAD DREAMS . LIGHT HEADACHE ALL DAY THIRD DAY (I DONT USUALLY GET HEADACHES .  FOURTH DAY I NOTICE MY HEART BEAT SEEMS A BIT ERRATIC. I CAN FEEL IT MORE THAN NORMAL AT TIMES.TODAY SOME RACING HEART BEATS NOT TERRIBLE BUT DIFFERENT
About 15 minutes after vaccination she reported feeling light headed and nauseous like the start of a panic attack. She tried to walk outside for fresh air, but had to sit down after about 20 feet of walking. She reported more nausea, feeling very hot, and had a hard time communicating. She was given a cool washcloth and fanned while being held up by a support person. Her blood pressure was initially high, and rose significantly over a period of about 5 minutes. Blood sugar was checked and was 475 mg/dL. 911 was called, and after about 10 minutes of supportive care paramedics transported her to the hospital. She was fairly limp at time of transport and had a hard time standing. The facility staff updated me several hours later that they had heard that she was doing well. It appeared to be a panic attack.
Patient received dose 1 of Moderna covid-19 vaccine in L deltoid. approx. 15 minutes after receiving vaccine while in observation area patient reported right 4th finger numbness and swelling in addition to nausea and dizziness, denies difficulty breathing/no facial swelling noted. Pt also reporting L ear numbness. Allergy MD on call paged & pt taken to ED for observation.
Your vaccine sucks is not effective; Your vaccine sucks is not effective; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP),. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Your vaccine sucks is not effective". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Monday night after the vaccine my arm turned red and hot and started hurting. Tuesday the next day the redness increased to a circle about 4inches x 4inches and I had a severe headache with aching in all of my joints and my arm increased in pain immensely and the red circle on my arm turned increased in redness and it turned hard. That night I could not sleep since everything in my body hurt so much. Wednesday the body aches went away but the red circle on my arm was getting larger and I still felt not myself. Thursday the redness was bigger and still hurt I took a prednisone 20mg and put Benadryl cream on it. It feels a little better.
Pt recvd 2 doses of Engerix-B & devel diarrhea, fever, (jaundiced) yellow skin, chills, dark urine, light stools, vomiting; flu or flu like rxn;
Developed paresthesia (tingling, pins and needles) in legs and arms, intermittent, moves around; more predominant in feet and hands; tender left supraclavicular lymphadenopathy (same side as vaccine administration); This is a spontaneous report from a contactable physician (patient). A 50-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot Number: EN6203), dose 2 via an unspecified route of administration, administered in Arm Left on 03Mar2021 11:30 (at the age of 50 years old) as 2nd dose, single for COVID-19 immunization. Medical history included paraesthesia (10 years ago) lasting approximately 8 weeks, diagnostic evaluation was negative, self-resolved (no history of vaccination then), hypercholesterolaemia from an unknown date and unknown if ongoing. No known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included atorvastatin. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot Number: EL3247), dose 1 via an unspecified route of administration, administered in Arm Left on 10Feb2021 12:15 as 1st dose, single for COVID-19 immunization. 06Mar2021 13:00, the patient developed paraesthesia (tingling, pins, and needles) in legs and arms, intermittent, moves around and more predominant in feet and hands. The patient also had tender left supraclavicular lymphadenopathy same side as vaccine administration. The patient did not receive any treatment for the events. The clinical outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Lt arm - red & warm to touch from mid arm down to elbow - 6" long & 4 1/2" around starts below deltoid area down to elbow. No induration (+) soft tissue swelling.
After vaccination,  patient reported "feeling light headed and weird". Pt pale and clammy. Vss. Cool air and liquid given. Seat reclined. PT quickly improved. After 20 minutes pt reported "feeling fine". VSS throughout.  D/c'd home.